PL2529735T3 - Compositions comprising 4-(heterocycloalkyl)benzene-1,3-diol derivatives with tyrosinase enzyme inhibiting activity - Google Patents

Compositions comprising 4-(heterocycloalkyl)benzene-1,3-diol derivatives with tyrosinase enzyme inhibiting activity

Info

Publication number: PL2529735T3
Authority: PL; Poland
Prior art keywords: heterocycloalkyl; benzene; compositions; inhibiting activity; enzyme inhibiting
Prior art date: 2008-12-02

Application number

PL12182351T

Other languages

Polish (pl)

Inventor

Jean-Guy Boiteau

Jean-Claude Pascal

Original Assignee

Galderma Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-02

Filing date

2009-12-02

Publication date

2015-01-30

2009-12-02 Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev

2015-01-30 Publication of PL2529735T3 publication Critical patent/PL2529735T3/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Furan Compounds (AREA)
Pyrane Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL12182351T 2008-12-02 2009-12-02 Compositions comprising 4-(heterocycloalkyl)benzene-1,3-diol derivatives with tyrosinase enzyme inhibiting activity PL2529735T3 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR0858206A FR2939136B1 (en)	2008-12-02	2008-12-02	NOVEL 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS
US20212809P	2009-01-30	2009-01-30
EP09796990A EP2373310B1 (en)	2008-12-02	2009-12-02	Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
EP12182351.2A EP2529735B1 (en)	2008-12-02	2009-12-02	Compositions comprising 4-(heterocycloalkyl)benzene-1,3-diol derivatives with tyrosinase enzyme inhibiting activity

Publications (1)

Publication Number	Publication Date
PL2529735T3 true PL2529735T3 (en)	2015-01-30

Family

ID=40845880

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL09796990T PL2373310T3 (en)	2008-12-02	2009-12-02	Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
PL12182351T PL2529735T3 (en)	2008-12-02	2009-12-02	Compositions comprising 4-(heterocycloalkyl)benzene-1,3-diol derivatives with tyrosinase enzyme inhibiting activity

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL09796990T PL2373310T3 (en)	2008-12-02	2009-12-02	Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics

Country Status (20)

Country	Link
US (1)	US8372879B2 (en)
EP (2)	EP2373310B1 (en)
JP (1)	JP5395188B2 (en)
KR (1)	KR101290504B1 (en)
CN (1)	CN102238948B (en)
AR (1)	AR074454A1 (en)
AU (1)	AU2009324080B2 (en)
BR (1)	BRPI0916504B8 (en)
CA (1)	CA2742703C (en)
DK (1)	DK2373310T3 (en)
ES (2)	ES2506265T3 (en)
FR (1)	FR2939136B1 (en)
HR (1)	HRP20120954T1 (en)
MX (1)	MX2011005479A (en)
PL (2)	PL2373310T3 (en)
PT (1)	PT2373310E (en)
RU (1)	RU2482116C2 (en)
SI (1)	SI2373310T1 (en)
SM (1)	SMT201200057B (en)
WO (1)	WO2010063773A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2939135B1 (en) *	2008-12-02	2010-12-03	Galderma Res & Dev	NOVEL 4- (AZACYCLOALKYL) -BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS
US8835488B2 (en) *	2011-03-23	2014-09-16	Trevena, Inc.	Opioid receptor ligands and methods of using and making same
EP2956449B1 (en) *	2013-02-14	2017-06-28	Galderma Research & Development	Process for the preparation of 4-(heterocycloalkyl)-benzene-1,3-diol compounds
WO2014139080A1 (en) *	2013-03-12	2014-09-18	Boehringer Ingelheim International Trading (Shanghai) Co., Ltd.	Novel process for the manufacture of 3-oxo-tetrahydrofuran
FR3030249B1 (en) *	2014-12-22	2018-11-02	L'oreal	AQUEOUS COMPOSITION COMPRISING A 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUND, A POLYMER AND A GLYCOL
FR3030252B1 (en) *	2014-12-22	2018-11-02	L'oreal	AQUEOUS COMPOSITION COMPRISING A 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUND, A C2-C4 MONOALCOOL AND A GLYCOL
FR3030251B1 (en) *	2014-12-22	2018-11-02	L'oreal	COMPOSITION COMPRISING 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUND AND A PARTICULATE SOLVENT
FR3030250B1 (en) *	2014-12-22	2018-11-02	L'oreal	AQUEOUS COMPOSITION COMPRISING A 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUND AND A HYDROTROPE
JP6873598B2 (en) *	2015-12-22	2021-05-19	ロレアル	Improved topical delivery system for active ingredients

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0651619B2 (en)	1988-05-09	1994-07-06	株式会社クラレ	Whitening agent
FR2704428B1 (en)	1993-04-29	1995-06-09	Oreal	Use of derivatives of resorcin substituted in position (s) 4, 4 and 5 or 4 and 6 in cosmetic or dermopharmaceutical compositions with depigmenting action.
US6068834A (en) *	1994-03-04	2000-05-30	The Procter & Gamble Company	Skin lightening compositions
BR9803596A (en) *	1997-09-23	2000-04-25	Pfizer Prod Inc	Derivatives of resorcinol.
JPH11255637A (en) *	1998-03-13	1999-09-21	Kansai Kouso Kk	Tyrosinase activity inhibitor and cosmetic
HN2000000033A (en) *	1999-03-22	2001-02-02	Pfizer Prod Inc	RESORCINOL COMPOSITION
JP2004508343A (en) *	2000-09-07	2004-03-18	ウイスコンシン　アラムニ　リサーチ　ファンデーション	Synthesis of 17F-labeled fluoroalkane
BR0113798A (en) *	2000-09-11	2003-07-08	Pfizer Prod Inc	Resorcinol Derivatives
US6852310B2 (en)	2002-08-23	2005-02-08	Unilever Home & Personal Care Usa Division Of Conopco, Inc.	Skin lightening agents, compositions and methods
US6875425B2 (en) *	2002-12-12	2005-04-05	Unilever Home & Personal Care Usa	Skin lightening agents, compositions and methods
US7300646B2 (en)	2004-02-27	2007-11-27	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Skin lightening agents, compositions and methods
US20060210497A1 (en)	2005-03-18	2006-09-21	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Novel resorcinol derivatives
US20060210498A1 (en)	2005-03-18	2006-09-21	Unilever Home & Personal Care Usa, Division Of Conopco, Inc.	Novel resorcinol derivatives for skin
FR2917087B1 (en) *	2007-06-05	2012-09-21	Galderma Res & Dev	NOVEL 4-PHENYL-IMIDAZOLE-2-THIONES AS INHIBITORS OF TYROSINASE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS

2008
- 2008-12-02 FR FR0858206A patent/FR2939136B1/en not_active Expired - Fee Related
2009
- 2009-12-02 JP JP2011538010A patent/JP5395188B2/en not_active Expired - Fee Related
- 2009-12-02 CN CN200980148286.5A patent/CN102238948B/en not_active Expired - Fee Related
- 2009-12-02 HR HRP20120954AT patent/HRP20120954T1/en unknown
- 2009-12-02 MX MX2011005479A patent/MX2011005479A/en active IP Right Grant
- 2009-12-02 ES ES12182351.2T patent/ES2506265T3/en active Active
- 2009-12-02 SI SI200930399T patent/SI2373310T1/en unknown
- 2009-12-02 US US13/131,161 patent/US8372879B2/en not_active Expired - Fee Related
- 2009-12-02 PL PL09796990T patent/PL2373310T3/en unknown
- 2009-12-02 KR KR1020117015284A patent/KR101290504B1/en not_active Expired - Fee Related
- 2009-12-02 WO PCT/EP2009/066267 patent/WO2010063773A1/en not_active Ceased
- 2009-12-02 EP EP09796990A patent/EP2373310B1/en not_active Not-in-force
- 2009-12-02 PL PL12182351T patent/PL2529735T3/en unknown
- 2009-12-02 AU AU2009324080A patent/AU2009324080B2/en not_active Ceased
- 2009-12-02 EP EP12182351.2A patent/EP2529735B1/en not_active Not-in-force
- 2009-12-02 PT PT97969901T patent/PT2373310E/en unknown
- 2009-12-02 AR ARP090104649A patent/AR074454A1/en unknown
- 2009-12-02 RU RU2011127120/04A patent/RU2482116C2/en active
- 2009-12-02 ES ES09796990T patent/ES2393916T3/en active Active
- 2009-12-02 DK DK09796990.1T patent/DK2373310T3/en active
- 2009-12-02 CA CA2742703A patent/CA2742703C/en active Active
- 2009-12-02 BR BRPI0916504A patent/BRPI0916504B8/en not_active IP Right Cessation
2012
- 2012-11-30 SM SM201200057T patent/SMT201200057B/en unknown

Also Published As

Publication number	Publication date
DK2373310T3 (en)	2012-12-17
BRPI0916504A2 (en)	2015-11-10
FR2939136B1 (en)	2010-12-03
EP2373310B1 (en)	2012-10-10
PL2373310T3 (en)	2013-02-28
EP2373310A1 (en)	2011-10-12
ES2393916T3 (en)	2013-01-02
BRPI0916504B1 (en)	2018-12-18
CA2742703A1 (en)	2010-06-10
CN102238948A (en)	2011-11-09
FR2939136A1 (en)	2010-06-04
RU2011127120A (en)	2013-01-20
US8372879B2 (en)	2013-02-12
BRPI0916504B8 (en)	2019-04-02
RU2482116C2 (en)	2013-05-20
JP2012510452A (en)	2012-05-10
HRP20120954T1 (en)	2012-12-31
SMT201200057B (en)	2013-01-14
US20120041213A1 (en)	2012-02-16
AR074454A1 (en)	2011-01-19
AU2009324080B2 (en)	2012-10-04
MX2011005479A (en)	2011-06-20
CA2742703C (en)	2014-04-08
SI2373310T1 (en)	2013-01-31
ES2506265T3 (en)	2014-10-13
AU2009324080A1 (en)	2010-06-10
EP2529735A1 (en)	2012-12-05
KR20110091583A (en)	2011-08-11
CN102238948B (en)	2015-03-25
EP2529735B1 (en)	2014-06-25
KR101290504B1 (en)	2013-07-29
WO2010063773A1 (en)	2010-06-10
PT2373310E (en)	2012-12-06
JP5395188B2 (en)	2014-01-22

Publication	Publication Date	Title
PL2529735T3 (en)	2015-01-30	Compositions comprising 4-(heterocycloalkyl)benzene-1,3-diol derivatives with tyrosinase enzyme inhibiting activity
LTPA2018510I1 (en)	2018-09-25	Derivatives of dioxa-bicyclo [3.2.1] octane-2,3,4-triol
LTPA2017039I1 (en)	2017-12-11	Pyrolopyrimidine compounds as inhibitors of CDK
BRPI0906973A2 (en)	2015-07-14	Compounds and compositions as kinase inhibitors.
PL2271660T3 (en)	2020-11-02	Stabilized liquid enzyme compositions
IL210195A0 (en)	2011-03-31	Benzoxazines, benzothazines, and related compounds having nos inhibitory activity
LT2280687T (en)	2019-08-26	RUBBER RUBBER COMPOSITIONS INCLUDING CANNABINOIDS
AP2010005380A0 (en)	2010-08-31	Extracellular matrix compositions.
EP2513022A4 (en)	2014-06-18	CIS-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AZEOTROPE COMPOSITIONS
SI2321235T1 (en)	2019-11-29	USE OF THE CABLET CONTROLLING COMPOSITION CONTAINED
BRPI1010301A2 (en)	2016-03-15	composition.
AP2010005465A0 (en)	2010-12-31	Pesticidal compositions.
IT1392101B1 (en)	2012-02-09	COMPOSITION INCLUDING ISOFLAVON
EP2421368A4 (en)	2013-01-09	COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING PYRIDAZINE SULFONAMIDE DERIVATIVES
BRPI0907584A2 (en)	2015-07-21	Compound and compositions as gpr119 activity modulators
ECSP12011946A (en)	2012-07-31	DERIVATIVES OF DIOXA- BICYCLE [3.2.1] OCTANO- 2, 3,4- TRIOL
DK3196302T3 (en)	2020-09-14	SMALL ENZYME GRANULES
NL1036050C (en)	2010-04-13	FIRE-DELAYING AND FIRE-RESISTING COMPOSITION.
BRPI0812865A2 (en)	2014-10-07	6-ANYLINOPURINE DERIVATIVES REPLACED AS CYTOKININE OXIDASE / DEHYDROGENASE INHIBITORS AND PREPARATIONS CONTAINING THESE DERIVATIVES.
BRPI0920287A2 (en)	2016-02-16	dishwashing composition
BRPI0917172A2 (en)	2015-08-04	Bacterial composition
BRPI1011460A2 (en)	2015-08-25	Disinfectant composition.
BRPI0917982A2 (en)	2015-11-17	particulate targeting composition comprising enzymes
EP2091530A4 (en)	2010-08-04	COMPOSITION FOR INHIBITING NADPH OXIDASE ACTIVITY
BRPI0916320A2 (en)	2018-02-06	agricultural compositions